Materias dentro de su búsqueda.
Mostrando 321 - 340 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 0.35s Limitar resultados
  1. 321
    “…INTRODUCTION: Diabetes mellitus (DM) has the potential to impact the pathogenesis, treatment, and outcome of pancreatic cancer. This study evaluates the impact of DM on pancreatic cancer survival. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of Diabetes Mellitus on the Outcome of Pancreatic Cancer
  2. 322
    “…In addition, traditional chemotherapy does not show ideal results because pancreatic cancer (PC) exhibits hypovascular characteristics. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Role of Endoscopic Ultrasound in Treatment of Pancreatic Cancer
  3. 323
    “…In recent years, increasing evidences support the use of neoadjuvant strategies in pancreatic cancer in patients with resectable pancreatic cancer as well as in patients with borderline resectable or locally advanced PDAC in order to allow early treatment of micrometastatic disease, tumour regression, and reduced risk of peritoneal tumour implantation during surgery. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy
  4. 324
    “…A single Phase II study has evaluated combination therapy with ixabepilone in the management of patients with pancreatic cancer, pairing it with cetuximab with clinical benefit. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Profile and potential of ixabepilone in the treatment of pancreatic cancer
  5. 325
    por Mielgo, Ainhoa, Schmid, Michael C.
    Publicado 2013
    “…Here we will review the current understanding of the biology and the pro-tumourigenic functions of TAMs in cancer and specifically in PDA, and highlight potential therapeutic strategies to target TAMs and to improve current therapies for pancreatic cancer. [BMB Reports 2013; 46(3): 131-138]…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of tumour associated macrophages in pancreatic cancer
  6. 326
    “…OBJECTIVE: Pancreatic cancer is a leading cause of cancer-related death in the Western world. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Targeting mTOR dependency in pancreatic cancer
  7. 327
    por Yu, Ji Hoon, Kim, Hyeyoung
    Publicado 2014
    “…Pancreatic cancer is one of the most aggressive, drug-resistant and lethal types of cancer with poor prognosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Oxidative Stress and Cytokines in the Pathogenesis of Pancreatic Cancer
  8. 328
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Targeting IL-17 for pancreatic cancer prevention
  9. 329
    “…[Image: see text] Patients with pancreatic cancer (PC) are usually diagnosed at late stages, when the disease is nearly incurable. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Plasma Metabolite Biomarkers for the Detection of Pancreatic Cancer
  10. 330
    “…In order to identify targets whose inhibition may enhance the efficacy of chemoradiation in pancreatic cancer, we previously conducted an RNAi library screen of 8,800 genes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Targeting Mcl-1 for Radiosensitization of Pancreatic Cancers()()
  11. 331
    “…The correlation between hypoxia and pancreatic cancer has long been discussed. Hao’s research team made many efforts on revealing the oncogenic function of hypoxic inducible factor-1 (HIF-1) in pancreatic cancer progression and development in recent years. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Targeting the hypoxia pathway to treat pancreatic cancer
  12. 332
    “…BACKGROUND: Pancreatic cancer (PancCa) is recognized as a component of many well-described hereditary cancer syndromes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Patient experiences living with pancreatic cancer risk
  13. 333
    “…However, to our knowledge, there has been no study to characterize its usefulness as a serum marker for human pancreatic cancer. Furthermore, the relation between survivin expression and the serum level of survivin has not been widely studied in PDAC. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Survivin expression and serum levels in pancreatic cancer
  14. 334
    por Demir, Ihsan Ekin, Friess, Helmut
    Publicado 2015
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pancreatic cancer — lessons from the past decade
  15. 335
    “…BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer death in Western countries, with the lowest 1-year survival rate among commonly diagnosed cancers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Salivary MicroRNA in Pancreatic Cancer Patients
  16. 336
    por Fulda, Simone
    Publicado 2009
    “…Resistance to apoptosis (programmed cell death) is a characteristic feature of human malignancies including pancreatic cancer, which is one of the leading causes of cancer deaths in the western world. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Apoptosis pathways and their therapeutic exploitation in pancreatic cancer
  17. 337
    por Dal Molin, Marco, Wood, Laura D
    Publicado 2015
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Very long-term survival in pancreatic cancer
  18. 338
    “…BACKGROUND: Advanced, unresectable pancreatic cancer is an extremely aggressive disease. The 5-year survival rate for pancreatic cancer is only less than 5%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer
  19. 339
    “…The multivariate model showed a better performance and it could represent a novel panel of serum cytokines that correlates to poor prognosis in pancreatic cancer. B7-1/CD80, EG-VEGF/PK1, IL-29, NRG1-beta1/HRG1-beta1, and PD-ECGF expressions portend a poor prognosis for patients with pancreatic cancer and these cytokines could represent novel therapeutic targets for this disease.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prognosis Relevance of Serum Cytokines in Pancreatic Cancer
  20. 340
    “…Here we examined the susceptibility of pancreatic cancer stem cells (CSC) and non-CSC to reprogramming. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Susceptibility of pancreatic cancer stem cells to reprogramming
Herramientas de búsqueda: RSS